Quick Answer
Compass Therapeutics, Inc. reported Net Income of -$66.49 million for fiscal year 2025.
Compass Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$66.49M | -34.7% |
| 2024 | -$49.38M | -16.2% |
| 2023 | -$42.49M | -8.3% |
| 2022 | -$39.23M | +52.3% |
| 2021 | -$82.18M | -178.6% |
| 2020 | -$29.50M | -78602.3% |
| 2020 | -$37.5K | +99.9% |
| 2019 | -$34.74M | -96312.0% |
| 2019 | -$36.0K | -2.8% |
| 2018 | -$35.1K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.26M | -36.0% | +28.3% |
| June 30, 2025 | -$19.88M | -52.0% | -19.5% |
| March 31, 2025 | -$16.63M | -54.2% | -58.7% |
| September 30, 2024 | -$10.48M | -5.2% | +19.8% |
| June 30, 2024 | -$13.08M | -15.9% | -21.2% |
| March 31, 2024 | -$10.79M | -37.6% | -8.3% |
| September 30, 2023 | -$9.96M | +16.8% | +11.7% |
| June 30, 2023 | -$11.28M | -32.8% | -43.9% |
- Compass Therapeutics, Inc. showed a decrease of -34.7% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Compass Therapeutics, Inc.’s net income has declined by 189586.8% (from -$35.1 thousand to -$66.49 million).
- The most recent figure is from Compass Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: